C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells

scientific article

C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1002/PROS.20159
P698PubMed publication ID15486993

P2093author name stringDaniel C Sanford
James W DeWille
P2860cites workCCAAT/enhancer-binding proteins: structure, function and regulationQ24534323
Interleukin-6-specific activation of the C/EBPdelta gene in hepatocytes is mediated by Stat3 and Sp1.Q33995164
Molecular basis of the cell specificity of cytokine actionQ34991814
Elevated levels of members of the STAT family of transcription factors in breast carcinoma nuclear extractsQ36080795
Opposite regulation of myc and p21waf1 transcription by STAT3 proteinsQ38360847
C/EBPalpha and C/EBPdelta activate the clara cell secretory protein gene through interaction with two adjacent C/EBP-binding sitesQ40890027
Accelerated in vivo growth of prostate tumors that up-regulate interleukin-6 is associated with reduced retinoblastoma protein expression and activation of the mitogen-activated protein kinase pathwayQ42855019
P433issue2
P304page(s)143-154
P577publication date2005-05-01
P1433published inThe ProstateQ7758608
P1476titleC/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells
P478volume63

Reverse relations

cites work (P2860)
Q33853380An integrative approach to identifying cancer chemoresistance-associated pathways
Q35052847Biological roles of CCAAT/Enhancer-binding protein delta during inflammation
Q33745060C/EBPδ gene targets in human keratinocytes.
Q34419342CCAAT/Enhancer Binding Protein-delta (C/EBP-delta) regulates cell growth, migration and differentiation
Q91947769CCAAT/enhancer binding protein delta (C/EBPδ) demonstrates a dichotomous role in tumour initiation and promotion of epithelial carcinoma
Q38433931Characterization of the roles of suppressor of cytokine signaling-3 in prostate cancer development and progression
Q38112122Dissecting Major Signaling Pathways throughout the Development of Prostate Cancer
Q37142723Epigenetic silencing of CCAAT/enhancer-binding protein delta activity by YY1/polycomb group/DNA methyltransferase complex
Q40114720Expression levels of the JAK/STAT pathway in the transition from hormone-sensitive to hormone-refractory prostate cancer.
Q33419487Frankincense oil derived from Boswellia carteri induces tumor cell specific cytotoxicity
Q90291453IL-6 signaling contributes to radioresistance of prostate cancer through key DNA repair-associated molecules ATM, ATR, and BRCA 1/2
Q55095957In-Silico Integration Approach to Identify a Key miRNA Regulating a Gene Network in Aggressive Prostate Cancer.
Q36562147Interleukin 6 trigged ataxia-telangiectasia mutated activation facilitates lung cancer metastasis via MMP-3/MMP-13 up-regulation
Q95326605Maternal administration of probiotics promotes brain development and protects offspring's brain from postnatal inflammatory insults in C57/BL6J mice
Q33888111Myc interacts with Max and Miz1 to repress C/EBPdelta promoter activity and gene expression
Q36233076Neuropeptide-inducible upregulation of proteasome activity precedes nuclear factor kappa B activation in androgen-independent prostate cancer cells
Q39020147Pharmacologic suppression of JAK1/2 by JAK1/2 inhibitor AZD1480 potently inhibits IL-6-induced experimental prostate cancer metastases formation
Q33300780Reciprocal regulation of p63 by C/EBP delta in human keratinocytes
Q33508314Requirement for nuclear factor kappa B signalling in the interleukin-1-induced expression of the CCAAT/enhancer binding protein-delta gene in hepatocytes
Q39099310Stat3 activation links a C/EBPδ to myostatin pathway to stimulate loss of muscle mass
Q37418549The C/EBPδ protein is stabilized by estrogen receptor α activity, inhibits SNAI2 expression and associates with good prognosis in breast cancer.
Q36836686The NF-kappaB/IL-6 pathway in metastatic androgen-independent prostate cancer: new therapeutic approaches?
Q36126920The androgen receptor and signal-transduction pathways in hormone-refractory prostate cancer. Part 2: Androgen-receptor cofactors and bypass pathways
Q84637813The cell growth inhibitory transcription factor C/EBPdelta is expressed in human meningiomas in association with low histological grade and proliferation index
Q34494671The extended TILAR approach: a novel tool for dynamic modeling of the transcription factor network regulating the adaption to in vitro cultivation of murine hepatocytes
Q37249246The many faces of C/EBPδ and their relevance for inflammation and cancer
Q36650466Transcriptional up-regulation of SOD1 by CEBPD: a potential target for cisplatin resistant human urothelial carcinoma cells

Search more.